SURVIVAL AND DRUG PERSISTENCE IN PATIENTS WITH PULMONARY HYPERTENSION RECEIVING INHALED TREPROSTINIL AT DOSES GREATER THAN 54 MCG (9 BREATHS) 4 TIMES DAILY Article
Full Text via DOI: 10.1016/j.chest.2019.08.336
Web of Science: 000500199200041